Sökning: L773:1520 4804 OR L773:0022 2623 >
Mining Natural Prod...
Mining Natural Products for Macrocycles to Drug Difficult Targets
-
- Begnini, Fabio (författare)
- Uppsala universitet,Organisk kemi
-
- Poongavanam, Vasanthanathan (författare)
- Uppsala universitet,Organisk kemi
-
- Over, Bjorn (författare)
- AstraZeneca, Dept Med Chem Res & Early Dev, Early Cardiovasc Renal & Metab, BioPharmaceut R&D, S-43183 Mölndal, Sweden.
-
visa fler...
-
- Castaldo, Marie (författare)
- AstraZeneca, R&D, Discovery Sci, Discovery Biol, S-43183 Mölndal, Sweden.
-
- Geschwindner, Stefan (författare)
- AstraZeneca, R&D, Discovery Sci, Struct Biophys & Fragment Based Lead Generat, S-43183 Mölndal, Sweden.
-
- Johansson, Patrik (författare)
- AstraZeneca, R&D, Discovery Sci, Struct Biophys & Fragment Based Lead Generat, S-43183 Mölndal, Sweden.
-
- Tyagi, Mohit (författare)
- Uppsala universitet,Organisk kemi
-
- Tyrchan, Christian (författare)
- AstraZeneca, Dept Med Chem Res & Early Dev, BioPharmaceut R&D, Resp & Immunol, S-43183 Mölndal, Sweden.
-
- Wissler, Lisa (författare)
- AstraZeneca, R&D, Discovery Sci, Struct Biophys & Fragment Based Lead Generat, S-43183 Mölndal, Sweden.
-
- Sjo, Peter (författare)
- Drugs Neglected Dis Initiat DNDi, CH-1202 Geneva, Switzerland.
-
- Schiesser, Stefan (författare)
- AstraZeneca, Dept Med Chem Res & Early Dev, BioPharmaceut R&D, Resp & Immunol, S-43183 Mölndal, Sweden.
-
- Kihlberg, Jan (författare)
- Uppsala universitet,Organisk kemi
-
visa färre...
-
(creator_code:org_t)
- 2020-12-18
- 2021
- Engelska.
-
Ingår i: Journal of Medicinal Chemistry. - : American Chemical Society (ACS). - 0022-2623 .- 1520-4804. ; 64:2, s. 1054-1072
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://uu.diva-port... (primary) (Raw object)
-
https://pubs.acs.org...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Lead generation for difficult-to-drug targets that have large, featureless, and highly lipophilic or highly polar and/or flexible binding sites is highly challenging. Here, we describe how cores of macrocyclic natural products can serve as a high-quality in silico screening library that provides leads for difficult-to-drug targets. Two iterative rounds of docking of a carefully selected set of natural-product-derived cores led to the discovery of an uncharged macrocyclic inhibitor of the Keap1-Nrf2 protein- protein interaction, a particularly challenging target due to its highly polar binding site. The inhibitor displays cellular efficacy and is well-positioned for further optimization based on the structure of its complex with Keapl and synthetic access. We believe that our work will spur interest in using macrocyclic cores for in silico-based lead generation and also inspire the design of future macrocycle screening collections.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Läkemedelskemi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Medicinal Chemistry (hsv//eng)
Nyckelord
- PROTEIN-PROTEIN INTERACTION; SMALL MOLECULES; KELCH DOMAIN; PREDICTION; DISCOVERY; INHIBITORS; FRAGMENTS; PROGRAM; BIND; RULE
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Begnini, Fabio
-
Poongavanam, Vas ...
-
Over, Bjorn
-
Castaldo, Marie
-
Geschwindner, St ...
-
Johansson, Patri ...
-
visa fler...
-
Tyagi, Mohit
-
Tyrchan, Christi ...
-
Wissler, Lisa
-
Sjo, Peter
-
Schiesser, Stefa ...
-
Kihlberg, Jan
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Läkemedelskemi
- Artiklar i publikationen
-
Journal of Medic ...
- Av lärosätet
-
Uppsala universitet